A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition.

J Cell Biol 2001 Dec 24;155(7):1265-73. Epub 2001 Dec 24.

Howard Hughes Medical Institute and Department of Microbiology, University of California Medical Center, San Francisco, CA 94143, USA.

Kaposi's sarcoma-associated herpesvirus encodes two transmembrane proteins (modulator of immune recognition [MIR]1 and MIR2) that downregulate cell surface molecules (MHC-I, B7.2, and ICAM-1) involved in the immune recognition of infected cells. This downregulation results from enhanced endocytosis and subsequent endolysosomal degradation of the target proteins. Here, we show that expression of MIR1 and MIR2 leads to ubiquitination of the cytosolic tail of their target proteins and that ubiquitination is essential for their removal from the cell surface. MIR1 and MIR2 both contain cytosolic zinc fingers of the PHD subfamily, and these structures are required for this activity. In vitro, addition of a MIR2-glutathione S-transferase (GST) fusion protein to purified E1 and E2 enzymes leads to transfer of ubiquitin (Ub) to GST-containing targets in an ATP- and E2-dependent fashion; this reaction is abolished by mutation of the Zn-coordinating residues of the PHD domain. Thus, MIR2 defines a novel class of membrane-bound E3 Ub ligases that modulates the trafficking of host cell membrane proteins.

Download full-text PDF

Source
http://dx.doi.org/10.1083/jcb.200111010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199318PMC
December 2001

Publication Analysis

Top Keywords

immune recognition
12
involved immune
8
cell surface
8
mir1 mir2
8
target proteins
8
novel class
8
proteins
5
zinc fingers
4
mir2 cytosolic
4
cytosolic zinc
4
fingers phd
4
structures required
4
addition mir2-glutathione
4
mir2-glutathione s-transferase
4
vitro addition
4
activity vitro
4
subfamily structures
4
required activity
4
phd subfamily
4
essential removal
4

References

(Supplied by CrossRef)

Proc. Natl. Acad. Sci. USA. 1996

Immunity. 2001

EMBO J. 2001

Proc. Natl. Acad. Sci. USA. 2000

J. Clin. Invest. 2001

J. Cell Sci. 2001

Nature. 1995

Trends Microbiol. 1998

Immunol. Rev. 1999

Cell. 2001

Nat. Rev. Mol. Cell. Biol. 2001

Similar Publications